Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Defining the “Why” in Virtual Team Settings – Building Company Culture Virtually

    January 16, 2025 | Impetus Digital, Pharma tips, Pharma trends, Remote work, Virtual company culture, company culture, home office, pharma 2025, pharma culture, pharma office, top ten tips, work from home 

    Defining your team’s purpose in a virtual setting is crucial for success. Are your workflows clear and documentation accessible? Learn how these elements can transform team dynamics and boost productivity, laying the foundation for a strong virtual workplace.

    In the third video of our series on creating company culture in a virtual environment, we explore the importance of defining your team’s new “why” in the digital workspace. Learn how clear workflows and accessible documentation can solidify team unity and enhance productivity.

    3. Determine the Team’s New “Why” in the Virtual World Understanding and articulating the “why” behind your team’s operations in a virtual setting is crucial. Learn how team leaders can develop a robust framework and foundation that dictates how the team will function and collaborate effectively online. Spending time to clearly define these workflows and ensure that documentation is easily accessible will not only streamline processes but also strengthen the team’s commitment and clarity of purpose. By establishing these guidelines early, teams can enjoy long-term benefits, resulting in a more cohesive and productive virtual work environment.

    For additional resources on enhancing virtual team dynamics and to learn from our expertise in managing remote teams, visit our blog: https://www.impetusdigital.com/2020/11/03/top-10-tips-for-creating-company-culture/

    Enhance your leadership in virtual settings with Impetus Digital:

    Stay connected for more insights on fostering a positive virtual work culture:

    This content was provided by Impetus Digital

    Company Details

    - PMLiVE

    Impetus Digital

    Email
    Website

     Latest Content from  Impetus Digital 

    Top-5 Trends in Virtual KOL Engagement

    Register now for one of our upcoming webinars (February 26-28)

    Engaging with Different Perspectives – Top 10 Most Important Advisor Questions

    In this quick clip, we highlight a vital tip from our 'Top 10 Most Important Advisor Questions' – essential for enhancing your virtual collaboration strategies in Pharma and Life Sciences....

    Patient Advocate Engagement: A Customer Story

    Learn how our client executed a series of 3 virtual touchpoints with 5 rare disease patient advocates to:- Develop a better understanding of the current treatment landscape and lived patient...

    Tailored Marketing Strategies for Pharma – Top 10 Most Important Advisor Questions

    In this video, we explore another crucial aspect of advisor questions when developing your virtual advisory board touchpoints – a key component for success in today's diverse healthcare landscape. 7....

    Trends in Virtual Collaboration

    Join us for a look at the top-5 emerging virtual collaboration trends...

    Advisor Questions on Potential Data or Knowledge Gaps

    As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here's another one to keep in...

    On a journey to diverse, inclusive, and more efficient rare disease trials

    Although orphan drugs represent a sizeable portion of new drug approvals, most rare diseases still lack effective treatment. Even more so than for other conditions, rare disease management contains large care...

    Versatility! Top 10 benefits of virtual advisory boards

    Here's another great tip on why the benefits of virtual advisory boards are superior to in-person and hybrid advisory boards. #10. Versatility! Another major advantage of using a virtual platform...

    Clinical Trials Investigator and Patient Engagement Planning: A Customer Story

    In the early lead-up to our client’s multi-center Rare Disease Phase 3 Clinical Trial, they first conducted an internal engagement planning Longitudinal Expert Engagement Plan™ (LEEP™) to conduct an informal...

    New Playbook Alert: Virtual Patient Engagement

    Authentic patient engagement and insight-gathering are becoming must-haves in Pharma. However, multiple obstacles remain before patient-centricity becomes more than a buzzword. In our latest playbook, we take a deep dive...